Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: A randomized pilot implementation study.

Benzekri NA, Sambou JF, Tamba IT, Diatta JP, Sall I, Cisse O, Thiam M, Bassene G, Badji NM, Faye K, Sall F, Malomar JJ, Seydi M, Gottlieb GS.

PLoS One. 2019 Jul 18;14(7):e0219118. doi: 10.1371/journal.pone.0219118. eCollection 2019.

2.

Models to predict the public health impact of vaccine resistance: A systematic review.

Reid MC, Peebles K, Stansfield SE, Goodreau SM, Abernethy N, Gottlieb GS, Mittler JE, Herbeck JT.

Vaccine. 2019 Aug 14;37(35):4886-4895. doi: 10.1016/j.vaccine.2019.07.013. Epub 2019 Jul 12. Review.

PMID:
31307874
3.

The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections.

Bender AM, Simonetti FR, Kumar MR, Fray EJ, Bruner KM, Timmons AE, Tai KY, Jenike KM, Antar AAR, Liu PT, Ho YC, Raugi DN, Seydi M, Gottlieb GS, Okoye AA, Del Prete GQ, Picker LJ, Mankowski JL, Lifson JD, Siliciano JD, Laird GM, Barouch DH, Clements JE, Siliciano RF.

Cell Host Microbe. 2019 Jul 10;26(1):73-85.e4. doi: 10.1016/j.chom.2019.06.005.

PMID:
31295427
4.

Large, stable, contemporary interspecies recombination events in circulating human herpes simplex viruses.

Casto AM, Roychoudhury P, Xie H, Selke S, Perchetti GA, Wofford H, Huang ML, Verjans GMGM, Gottlieb GS, Wald A, Jerome KR, Koelle DM, Johnston C, Greninger AL.

J Infect Dis. 2019 Apr 23. pii: jiz199. doi: 10.1093/infdis/jiz199. [Epub ahead of print]

PMID:
31016321
5.

Traditional healers, HIV outcomes, and mortality among people living with HIV in Senegal, West Africa.

Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, Diatta JP, Faye K, Sall I, Sall F, Malomar JJ, Hawes SE, Seydi M, Gottlieb GS; UW-Senegal Research Collaboration.

AIDS. 2019 Jul 15;33(9):1521-1526. doi: 10.1097/QAD.0000000000002232.

PMID:
31008800
6.

Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.

Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, Diatta JP, Faye K, Sall I, Sall F, Manga NM, Malomar JJ, Ndour CT, Hawes SE, Seydi M, Gottlieb GS.

BMC Infect Dis. 2019 Mar 15;19(1):261. doi: 10.1186/s12879-019-3826-5.

7.

Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.

Smith RA, Raugi DN, Wu VH, Zavala CG, Song J, Diallo KM, Seydi M, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00014-19. doi: 10.1128/AAC.00014-19. Print 2019 May.

PMID:
30803972
8.

Correction: Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015.

Benzekri NA, Seydi M, N Doye I, Toure M, Sy MP, Kiviat NB, Sow PS, Gottlieb GS, Hawes SE.

PLoS One. 2019 Feb 7;14(2):e0212250. doi: 10.1371/journal.pone.0212250. eCollection 2019.

9.

Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015.

Benzekri NA, Seydi M, N Doye I, Toure M, Sy MP, Kiviat NB, Sow PS, Gottlieb GS, Hawes SE.

PLoS One. 2018 Dec 31;13(12):e0208635. doi: 10.1371/journal.pone.0208635. eCollection 2018. Erratum in: PLoS One. 2019 Feb 7;14(2):e0212250.

10.

Relational concurrency, stages of infection, and the evolution of HIV set point viral load.

Goodreau SM, Stansfield SE, Murphy JT, Peebles KC, Gottlieb GS, Abernethy NF, Herbeck JT, Mittler JE.

Virus Evol. 2018 Nov 21;4(2):vey032. doi: 10.1093/ve/vey032. eCollection 2018 Jul.

11.

SD-chip enabled quantitative detection of HIV RNA using digital nucleic acid sequence-based amplification (dNASBA).

Wang J, Kreutz JE, Thompson AM, Qin Y, Sheen AM, Wang J, Wu L, Xu S, Chang M, Raugi DN, Smith RA, Gottlieb GS, Chiu DT.

Lab Chip. 2018 Nov 6;18(22):3501-3506. doi: 10.1039/c8lc00956b.

PMID:
30351338
12.

Sexual role and HIV-1 set point viral load among men who have sex with men.

Stansfield SE, Mittler JE, Gottlieb GS, Murphy JT, Hamilton DT, Detels R, Wolinsky SM, Jacobson LP, Margolick JB, Rinaldo CR, Herbeck JT, Goodreau SM.

Epidemics. 2019 Mar;26:68-76. doi: 10.1016/j.epidem.2018.08.006. Epub 2018 Aug 30.

13.

Female genital mutilation and noninvasive cervical abnormalities and invasive cervical cancer in Senegal, West Africa: A retrospective study.

Osterman AL, Winer RL, Gottlieb GS, Sy MP, Ba S, Dembele B, Toure P, Dem A, Seydi M, Sall F, Sow PS, Kiviat NB, Hawes SE.

Int J Cancer. 2019 Mar 15;144(6):1302-1312. doi: 10.1002/ijc.31829. Epub 2018 Oct 31.

PMID:
30144025
14.

90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2.

Gottlieb GS, Raugi DN, Smith RA.

Lancet HIV. 2018 Jul;5(7):e390-e399. doi: 10.1016/S2352-3018(18)30094-8. Review.

PMID:
30052509
15.

In Vitro Antiviral Activity of Cabotegravir against HIV-2.

Smith RA, Wu VH, Zavala CG, Raugi DN, Ba S, Seydi M, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01299-18. doi: 10.1128/AAC.01299-18. Print 2018 Oct.

16.

HIV and the dual burden of malnutrition in Senegal, 1994-2012.

Benzekri NA, Seydi M, NDoye I, Toure M, Kiviat NB, Sow PS, Hawes SE, Gottlieb GS.

Int J STD AIDS. 2018 Oct;29(12):1165-1173. doi: 10.1177/0956462418777364. Epub 2018 Jun 18.

PMID:
29914295
17.

A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.

Ba S, Raugi DN, Smith RA, Sall F, Faye K, Hawes SE, Sow PS, Seydi M, Gottlieb GS; University of Washington–Dakar HIV-2 Study Group .

Clin Infect Dis. 2018 Oct 30;67(10):1588-1594. doi: 10.1093/cid/ciy324.

PMID:
29672676
18.

HIV Drug Resistance.

Gottlieb GS, Raugi DN, Smith RA; University of Washington-Dakar HIV-2 Study Group.

N Engl J Med. 2018 Mar 1;378(9):874-5. doi: 10.1056/NEJMc1716089. No abstract available.

PMID:
29504389
19.

HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.

Herbeck JT, Peebles K, Edlefsen PT, Rolland M, Murphy JT, Gottlieb GS, Abernethy N, Mullins JI, Mittler JE, Goodreau SM.

Vaccine. 2018 Jan 25;36(4):514-520. doi: 10.1016/j.vaccine.2017.12.004. Epub 2017 Dec 11.

20.

Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.

Chang M, Steinmetzer K, Raugi DN, Smith RA, Ba S, Sall F, Seydi M, Niang A, Sall EI, Cisse O, Rödel K, Coombs RW, Gottlieb GS.

J Clin Virol. 2017 Dec;97:22-25. doi: 10.1016/j.jcv.2017.10.013. Epub 2017 Oct 24.

21.

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.

Coffie PA, Tchounga BK, Bado G, Kabran M, Minta DK, Wandeler G, Gottlieb GS, Dabis F, Eholie SP, Ekouevi DK.

BMC Infect Dis. 2017 Jul 4;17(1):466. doi: 10.1186/s12879-017-2568-5.

22.

The dimensions of food insecurity and malnutrition among people living with HIV in Senegal, West Africa.

Benzekri NA, Sambou JF, Diaw B, Sall EHI, Sall F, Niang A, Ba S, Guèye NFN, Diallo MB, Hawes SE, Seydi M, Gottlieb GS.

AIDS Care. 2017 Dec;29(12):1510-1516. doi: 10.1080/09540121.2017.1338652. Epub 2017 Jun 14.

PMID:
28612658
23.

MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.

Wu VH, Smith RA, Masoum S, Raugi DN, Ba S, Seydi M, Grobler JA, Gottlieb GS; University of Washington–Dakar HIV-2 Study Group.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00744-17. doi: 10.1128/AAC.00744-17. Print 2017 Aug.

24.

A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Whitham HK, Hawes SE, Chu H, Oakes JM, Lifson AR, Kiviat NB, Sow PS, Gottlieb GS, Ba S, Sy MP, Kulasingam SL.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):886-894. doi: 10.1158/1055-9965.EPI-16-0700. Epub 2017 May 17.

25.

Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm.

Chang M, Wong AJ, Raugi DN, Smith RA, Seilie AM, Ortega JP, Bogusz KM, Sall F, Ba S, Seydi M, Gottlieb GS, Coombs RW.

J Clin Virol. 2017 Jan;86:56-61. doi: 10.1016/j.jcv.2016.11.011. Epub 2016 Nov 23.

26.

Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study.

Herbeck JT, Mittler JE, Gottlieb GS, Goodreau SM, Murphy JT, Cori A, Pickles M, Fraser C.

Virus Evol. 2016 Oct 3;2(2):vew028. doi: 10.1093/ve/vew028. eCollection 2016 Jul.

27.

Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors.

Raugi DN, Smith RA, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

J Virol. 2015 Nov 11;90(2):1062-9. doi: 10.1128/JVI.01772-15. Print 2016 Jan 15.

28.

High Prevalence of Severe Food Insecurity and Malnutrition among HIV-Infected Adults in Senegal, West Africa.

Benzekri NA, Sambou J, Diaw B, Sall el HI, Sall F, Niang A, Ba S, Ngom Guèye NF, Diallo MB, Hawes SE, Seydi M, Gottlieb GS.

PLoS One. 2015 Nov 3;10(11):e0141819. doi: 10.1371/journal.pone.0141819. eCollection 2015.

29.

The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.

Smith RA, Raugi DN, Wu VH, Leong SS, Parker KM, Oakes MK, Sow PS, Ba S, Seydi M, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

Antimicrob Agents Chemother. 2015 Dec;59(12):7437-46. doi: 10.1128/AAC.01326-15. Epub 2015 Sep 21.

30.

The association between HPV, intraepithelial lesions and HIV-1 shedding in anogenital specimens in two contrasting populations: Senegalese women and American MSM.

Hood JE, Gottlieb GS, Kiviat NB, Sow PS, Toure M, Feng Q, Hawes SE.

Int J STD AIDS. 2016 Apr;27(5):353-62. doi: 10.1177/0956462415580691. Epub 2015 Apr 24.

PMID:
25914409
31.

In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2.

Smith RA, Raugi DN, Pan C, Sow PS, Seydi M, Mullins JI, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

Retrovirology. 2015 Feb 5;12:10. doi: 10.1186/s12977-015-0146-8.

32.

Antiretroviral therapy response among HIV-2 infected patients: a systematic review.

Ekouevi DK, Tchounga BK, Coffie PA, Tegbe J, Anderson AM, Gottlieb GS, Vitoria M, Dabis F, Eholie SP.

BMC Infect Dis. 2014 Aug 26;14:461. doi: 10.1186/1471-2334-14-461. Review.

33.

An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load.

Herbeck JT, Mittler JE, Gottlieb GS, Mullins JI.

PLoS Comput Biol. 2014 Jun 19;10(6):e1003673. doi: 10.1371/journal.pcbi.1003673. eCollection 2014 Jun.

34.

Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal.

Hanisch RA, Cherne SL, Sow PS, Winer RL, Hughes JP, Feng Q, Gottlieb GS, Toure M, Dem A, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

Cancer Epidemiol. 2014 Aug;38(4):369-75. doi: 10.1016/j.canep.2014.04.005. Epub 2014 May 19.

PMID:
24852136
35.

A 58-year-old immunosuppressed male with chronic cough, diarrhea, and a new "pressure" ulcer.

Zaniello BA, Gottlieb GS.

J Clin Microbiol. 2014 Jan;52(1):1, 382. doi: 10.1128/JCM.02517-12. No abstract available.

36.

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

J Clin Virol. 2013 Dec;58(4):696-702. doi: 10.1016/j.jcv.2013.10.012. Epub 2013 Oct 18.

37.

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.

Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, Minga A, Sow PS, Bissagnene E, Eholie SP, Gottlieb GS, Dabis F; IeDEA West Africa collaboration, Zannou DM, Ahouada C, Akakpo J, Ahomadegbé C, Bashi J, Gougounon-Houéto A, Azon-Kouanou A, Houngbé F, Koumakpaï S, Alihonou F, d'Almeida M, Hodonou I, Hounhoui G, Sagbo G, Tossa-Bagnan L, Adjide H, Drabo J, Bognounou R, Dienderé A, Traore E, Zoungrana L, Zerbo B, Sawadogo AB, Zoungrana J, Héma A, Soré I, Bado G, Tapsoba A, Yé D, Kouéta F, Ouedraogo S, Ouédraogo R, Hiembo W, Gansonré M, Messou E, Gnokoro JC, Koné M, Kouakou GM, Bosse CA, Brou K, Assi AI, Chenal H, Hawerlander D, Soppi F, Minga A, Abo Y, Bomisso G, Eholié SP, Amego MD, Andavi V, Diallo Z, Ello F, Tanon AK, Koule SO, Anzan KC, Guehi C, Aka EA, Issouf KL, Kouakou JC, N'gbeche MS, Touré P, Avit-Edi D, Kouakou K, Moh M, Yao VA, Folquet MA, Dainguy ME, Kouakou C, Méa-Assande VT, Oka-Berete G, Zobo N, Acquah P, Kokora MB, Eboua TF, Timité-Konan M, Ahoussou LD, Assouan JK, Sami MF, Kouadio C, Renner L, Goka B, Welbeck J, Sackey A, Owiafe SN, Wejse C, Silva ZJ, Paulo J, Rodrigues A, da Silva D, Medina C, Oliviera-Souto I, Ostergaard L, Laursen A, Sodemann M, Aaby P, Fomsgaard A, Erikstrup C, Eugen-Olsen J, Maïga MY, Diakité FF, Kalle A, Katile D, Traore HA, Minta D, Cissé T, Dembelé M, Doumbia M, Fomba M, Kaya AS, Traoré AM, Traoré H, Toure AA, Dicko F, Sylla M, Berthé A, Traoré HC, Koïta A, Koné N, N'diaye C, Coulibaly ST, Traoré M, Traoré N, Charurat M, Ajayi S, Dapiap S, Otu, Igbinoba F, Benson O, Adebamowo C, James J, Obaseki, Osakede P, Olasode J, Sow PS, Diop B, Manga NM, Tine JM, Signate Sy H, Ba A, Diagne A, Dior H, Faye M, Gueye RD, Mbaye AD, Patassi A, Kotosso A, Kariyare BG, Gbadamassi G, Komi A, Mensah-Zukong KE, Pakpame P, Lawson-Evi AK, Atakouma Y, Takassi E, Djeha A, Ephoévi-Gah A, Djibril Sel-H, Dabis F, Bissagnene E, Arrivé E, Coffie P, Ekouevi D, Jaquet A, Leroy V, Lewden C, Sasco A, Azani JC, Allou G, Balestre E, Bohossou F, Karcher S, Gonsan JM, Carrou JL, Lenaud S, Nchot C, Malateste K, Yao AR, Siloué B, Clouet G, Djetouan H, Doring A, Kouakou A, Rabourdin E, Rivenc J, Anglaret X, Ba B, Essanin JB, Ciaranello A, Datté S, Desmonde S, Diby JS, Gottlieb GS, Horo AG, Kangah SN, Malvy D, Meless D, Mounkaila-Harouna A, Ndondoki C, Shiboski C, Thiébaut R, Pac-Ci, Abidjan.

PLoS One. 2013 Jun 18;8(6):e66135. doi: 10.1371/journal.pone.0066135. Print 2013.

38.

HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts.

Raugi DN, Gottlieb GS, Sow PS, Toure M, Sall F, Gaye A, N'doye I, Kiviat NB, Hawes SE; University of Washington-Dakar HIV Study Group.

AIDS. 2013 Sep 24;27(15):2441-50. doi: 10.1097/QAD.0b013e328362e856.

39.

Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy.

Raugi DN, Smith RA, Ba S, Toure M, Traore F, Sall F, Pan C, Blankenship L, Montano A, Olson J, Dia Badiane NM, Mullins JI, Kiviat NB, Hawes SE, Sow PS, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

Antimicrob Agents Chemother. 2013 Jun;57(6):2751-60. doi: 10.1128/AAC.00405-13. Epub 2013 Apr 9.

40.

Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.

Gottlieb GS.

AIDS. 2013 Jan 2;27(1):135-7. doi: 10.1097/QAD.0b013e32835a11a4. No abstract available.

41.

Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.

Heitzinger K, Sow PS, Dia Badiane NM, Gottlieb GS, N'Doye I, Toure M, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

Int J STD AIDS. 2012 Oct;23(10):710-6. doi: 10.1258/ijsa.2012.011219.

42.

Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens.

Smith RA, Raugi DN, Pan C, Coyne M, Hernandez A, Church B, Parker K, Mullins JI, Sow PS, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

PLoS One. 2012;7(9):e45372. doi: 10.1371/journal.pone.0045372. Epub 2012 Sep 18.

43.

Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.

Chang M, Gottlieb GS, Dragavon JA, Cherne SL, Kenney DL, Hawes SE, Smith RA, Kiviat NB, Sow PS, Coombs RW.

J Clin Virol. 2012 Oct;55(2):128-33. doi: 10.1016/j.jcv.2012.06.024. Epub 2012 Jul 24.

44.

HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.

Pavlinac PB, Hawes SE, Gottlieb GS, Gaye A, N'Diaye CF, Critchlow CW, Sow PS, Feng Q, Kiviat NB.

Sex Transm Infect. 2012 Feb;88(1):45-50. doi: 10.1136/sextrans-2011-050231.

45.

Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Herbeck JT, Müller V, Maust BS, Ledergerber B, Torti C, Di Giambenedetto S, Gras L, Günthard HF, Jacobson LP, Mullins JI, Gottlieb GS.

AIDS. 2012 Jan 14;26(2):193-205. doi: 10.1097/QAD.0b013e32834db418.

46.

Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.

Kong R, Li H, Bibollet-Ruche F, Decker JM, Zheng NN, Gottlieb GS, Kiviat NB, Sow PS, Georgiev I, Hahn BH, Kwong PD, Robinson JE, Shaw GM.

J Virol. 2012 Jan;86(2):947-60. doi: 10.1128/JVI.06155-11. Epub 2011 Oct 26.

47.

Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance.

Smith RA, Raugi DN, Kiviat NB, Hawes SE, Mullins JI, Sow PS, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group.

AIDS. 2011 Nov 28;25(18):2235-41. doi: 10.1097/QAD.0b013e32834d8e52.

48.

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.

Gottlieb GS, Smith RA, Dia Badiane NM, Ba S, Hawes SE, Toure M, Starling AK, Traore F, Sall F, Cherne SL, Stern J, Wong KG, Lu P, Kim M, Raugi DN, Lam A, Mullins JI, Kiviat NB; Papa Salif Sow for the UW-Dakar HIV-2 Study Group.

PLoS One. 2011;6(7):e22204. doi: 10.1371/journal.pone.0022204. Epub 2011 Jul 12.

49.

Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.

Zheng NN, McElrath MJ, Sow PS, Mesher A, Hawes SE, Stern J, Gottlieb GS, De Rosa SC, Kiviat NB.

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):92-100. doi: 10.1097/QAI.0b013e318215a877.

PMID:
21423026
50.

HIV-1 envelope subregion length variation during disease progression.

Curlin ME, Zioni R, Hawes SE, Liu Y, Deng W, Gottlieb GS, Zhu T, Mullins JI.

PLoS Pathog. 2010 Dec 16;6(12):e1001228. doi: 10.1371/journal.ppat.1001228.

Supplemental Content

Loading ...
Support Center